These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17096355)
1. Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma. Yashiro M; Nakazawa K; Tendo M; Kosaka K; Shinto O; Hirakawa K Int J Cancer; 2007 Feb; 120(3):686-93. PubMed ID: 17096355 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells. Tendo M; Yashiro M; Nakazawa K; Yamada N; Hirakawa K Cancer Sci; 2005 Jul; 96(7):451-5. PubMed ID: 16053517 [TBL] [Abstract][Full Text] [Related]
3. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Nakazawa K; Yashiro M; Hirakawa K Cancer Res; 2003 Dec; 63(24):8848-52. PubMed ID: 14695201 [TBL] [Abstract][Full Text] [Related]
4. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer. Yashiro M; Chung YS; Sowa M Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424 [TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling. Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219 [TBL] [Abstract][Full Text] [Related]
6. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells. Nagahara T; Okano J; Murawaki Y Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586 [TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. Uefuji K; Ichikura T; Shinomiya N; Mochizuki H Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer. Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799 [TBL] [Abstract][Full Text] [Related]
10. A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells. Tendo M; Yashiro M; Nakazawa K; Yamada N; Sawada T; Ohira M; Hirakawa K Cancer Lett; 2006 Dec; 244(2):247-51. PubMed ID: 16448745 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer. Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357 [TBL] [Abstract][Full Text] [Related]
12. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination. Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522. Sato N; Mizutani Y; Li YN; Fujiwara J; Ishida H; Toiyama D; Abe K; Hayashi I; Nakanishi H; Kawauchi A; Miki T Urol Int; 2010; 84(3):362-8. PubMed ID: 20389170 [TBL] [Abstract][Full Text] [Related]
14. JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats. Kobayashi H; Uetake H; Higuchi T; Enomoto M; Sugihara K BMC Cancer; 2005 Mar; 5():26. PubMed ID: 15743541 [TBL] [Abstract][Full Text] [Related]
15. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor. Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187 [TBL] [Abstract][Full Text] [Related]
16. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer. Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326 [TBL] [Abstract][Full Text] [Related]
17. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253 [TBL] [Abstract][Full Text] [Related]
18. Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer. Mizutani Y; Kamoi K; Ukimura O; Kawauchi A; Miki T J Urol; 2002 Dec; 168(6):2650-4. PubMed ID: 12442003 [TBL] [Abstract][Full Text] [Related]
19. Involvement of cyclooxygenase-2--prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells. Takehara H; Iwamoto J; Mizokami Y; Takahashi K; Ootubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Matsuoka T Dig Dis Sci; 2006 Dec; 51(12):2188-97. PubMed ID: 17078003 [TBL] [Abstract][Full Text] [Related]
20. Human colon fibroblasts induce differentiation and proliferation of intestinal epithelial cells through the direct paracrine action of keratinocyte growth factor. Visco V; Bava FA; d'Alessandro F; Cavallini M; Ziparo V; Torrisi MR J Cell Physiol; 2009 Jul; 220(1):204-13. PubMed ID: 19326389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]